Discussion

Sunday, March 9, 2025

7:56 PM - 8:01 PM ET

Panel Moderator(s)

Alexandre A. Abizaid, MD, PhD

Director of Invasive Cardiology
Incor
SÃO PAULO, Sao Paulo, Brazil

No relationships to disclose
Azeem Latib, MD

Director, Interventional Cardiology & Structural Heart Interventions
Montefiore Medical Center
Scarsdale, New York, United States

Disclosure(s): Boston Scientific, Metronic: Consulting Fees (e.g., advisory boards) (Ongoing)
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Panel Discussant(s)

Sandeep Basavarajaiah, MBBS, MD, MRCP, FESC

Consultant Cardiologist
National Health Service

No relationships to disclose
Antonio Colombo, MD

Professor of Cardiology
Humanitas IRCCS
Milan, Lombardia, Italy

No relationships to disclose
Bernardo Cortese, MD, FESC, FSCAI

Director of Coronary Program
University Hospitals
Cleveland, Ohio, United States

No relationships to disclose
Aloke V. Finn, MD

President CVPath/Prof. Of Medicine University of Maryland
CVPath
Gaithersburg, Maryland, United States

No relationships to disclose
Sahil A. Parikh, MD, FSCAI

Associate Professor of Medicine
Columbia University Irving Medical Center
New York, New York, United States

No relationships to disclose

Disclosure(s):

Alexandre A. Abizaid, MD, PhD: No financial relationships to disclose

Azeem Latib, MD: Boston Scientific, Metronic: Consulting Fees (e.g., advisory boards) (Ongoing)

Ron Waksman, MD, MSCAI: Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Sandeep Basavarajaiah, MBBS, MD, MRCP, FESC: Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Antonio Colombo, MD: No financial relationships to disclose

Bernardo Cortese, MD, FESC, FSCAI: Acrostak: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Angiodynamics/Auryon: Consulting Fees (e.g., advisory boards) (Ongoing); ANT: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BBraun: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Biotronik: Grant/Research Support (Ongoing); Brosmed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardionovum: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Concept Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis Inc.: Consultant (Ongoing); iVascular: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MedAlliance: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Aloke V. Finn, MD: Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Sahil A. Parikh, MD, FSCAI: Abbott Vascular: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Acotec: Grant/Research Support (Ongoing); Advanced NanoTherapies: Stock-privately held company (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Concept Medical: Grant/Research Support (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Efemoral Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Encompass vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); R3 Vascular: Grant/Research Support (Ongoing); Reflow Medical: Grant/Research Support (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Veryan Medical: Grant/Research Support (Ongoing)